Bavarian Nordic has repeated a recommendation that its shareholders accept a takeover offer from an investment consortium, saying updated terms are "fair and attractive." The Danish biopharma company ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果